CHRONIC HYPERTENSION AND PREGNANCY (CHAP) PROJECT ENROLLMENT
Researchers at NewYork-Presbyterian Queens are studying chronic hypertension and pregnancy. A common medical complication during pregnancy is chronic hyper- tension (CHTN). CHTN might exist before pregnancy or it might start during pregnancy. It occurs in 2-6% of pregnant women. Mild chronic hypertension is when the blood pressure (BP) is at least 140/90 but less than 160/105. Non-pregnant adults with mild CHTN are treated with medication to lower BP less than 140/90. However, it is not clear whether or not pregnant women should be treated with BP medication unless the BP reaches 160/105. The purpose of the CHAP study is to learn whether treating pregnant women with BP medicines to lower their BP below 140/90 is safe and beneficial for the mother and baby. Study visits will coincide with routine prenatal visits.
To enroll in the study, researchers at NYP Queens women that are less than 23 weeks pregnant, are pregnant with one baby, and have high blood pressure. Interested individuals can see if they qualify for enrollment by calling Susan Ingenito at the Theresa and Eugene M. Lang Center for Research and Education at NYP Queens, at 718-670-2414.
NYP Queens is one of investigative sites for this study. Daniel W. Skupski, Chairman, Department of OB/GYN at NYP Queens is also a co-investigator in the study.
CHAPS (Chronic Hypertension and Pregnancy) Project (ClinicalTrials.gov number: NCT02299414) is sponsored by University of Alabama at Birmingham.